SLT Holdings’s Achieve Life Sciences ACHV Stock Holding History

SLT Holdings’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-133,300	Closed	-$392K	–	151
2026 Q1	$392K	Buy	+133,300	New	+$592K	0.27%	86

Other funds holding ACHV

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Manchester Financial Westlake Village, California $563M AUM 21.72% 1-Year Est. Return

Members Wealth Media, Pennsylvania $182M AUM 15.09% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Windsor Capital Management Phoenix, Arizona $385M AUM 17.95% 1-Year Est. Return

SLT Holdings's ACHV Position: Q2 2026 in Review

SLT Holdings sold out of Achieve Life Sciences (ACHV) in Q2 2026, closing a stake of 9,500 shares — an estimated $27.9K sold.

SLT Holdings first reported a position in ACHV in Q1 2026 and held it in 1 quarter. The position peaked at $27.9K in Q1 2026. 7 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

SLT Holdings reported no remaining Achieve Life Sciences position as of Q2 2026 after selling out during the quarter.
SLT Holdings sold 9,500 Achieve Life Sciences shares in Q2 2026, an estimated $27.9K.
SLT Holdings first reported a position in Achieve Life Sciences in Q1 2026 and held it in 1 quarter.
SLT Holdings's Achieve Life Sciences position peaked at $27.9K in Q1 2026.
7 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on SLT Holdings's 13F filing for Q2 2026, filed 17 Jul 2026.